?

BIOGRAPHICAL SKETCH

?

NAME: Duanming Du

?

POSITION TITLE: Professor

?

EDUCATION/TRAINING

?

A. Personal statement

I have more than 20 years of experience researching interventional therapies for tumor and vascular diseases. In the past five years, I have obtained over ￥300,000 in funding from the Shenzhen Science and Technology R & D Fund. I have also published 11 high-level academic papers in Int J Clin Exp Med and similar journals as first author or corresponding author.

?

B. Positions and honors

Positions

2011-present: Department Director, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People’s Hospital, Shenzhen, China

?

Honors

2020-present:?Vice President,?Intervention Medicine Branch of Shenzhen Hospital Association, Shenzhen, China

?

2020-present?Member of the Standing Committee, Intervention Branch of the Guangdong Medical Doctor Association, Guangdong, China

?

2019-present:?Member of the Standing Committee, Asian Society of Cryosurgery

?

2019-present:?Member, Intervention Radiology Branch of the Chinese Medical Association, China

?

2019-present:?Vice?Chairman, Intervention Diagnosis and Treatment Committee of the Shenzhen Medical Association, Shenzhen, China

?

2019-present:?Member of the Standing Committee, Intervention Medicine Branch of the Guangdong Hospital Association, Guangdong, China

?

2019-present:?President, Intervention Branch of Shenzhen Medical Doctor Association, Shenzhen, China

?

2018-present:?Vice Chairman, Intervention Medicine Committee of the Guangdong Health Management Association, Guangdong, China

?

2018-present: Member, Intervention Branch of the Chinese Medical Doctor Association, China

?

2018-present:?Member, Intervention Committee of Liver Cancer Committee of the Chinese Medical Association, China

?

2017-present?Member of the Standing Committee, Intervention Medicine Branch of the Guangdong Medical Association, Guangdong, China

?

2017-present:?Member of the Standing Committee, Cancer Microinvasive Intervention Committee of the Guangdong Anti-Cancer Association, Guangdong, China

?

2017-present:?Member of the Standing Committee, Cancer Interventional Therapy Committee of the Guangdong Association of Chinese Integrative Medicine, Guangdong, China

?

2017-present:?Member of the Editorial Board, Chinese Journal of Interventional Imaging and Therapy, China

?

2016-present:?Director, International Society of Cryosurgery

?

2013-2017 Vice Chairman, Cancer Interventional Therapy Committee of the Shenzhen Anti-Cancer Association, Shenzhen, China

?

2012-2017 Member of the Standing Committee, General intervention Committee of the Guangdong Association of Chinese Integrative Medicine, Guangdong, China

?

Reviewer, Journal of Clinical Hepatology, China

?

Reviewer, Chinese Journal of Clinical Oncology, China

?

?

C. Representative publications (selected publications from the past five years ? 5-10篇)

?

1.?Duanming Du, Leichang Jiang, Shuibo Qiu and Ruming Zhou (2016) Efficacy of neoadjuvant chemotherapy in breast cancer: arterial infusion chemotherapy vs intravenous chemotherapy.?Int J Clin Exp Med,?9(7): 14240-14246.

2.?Mao Lin,?Mohammed Alnaggar, Shuzhen Liang, Jibing Chen, Kecheng Xu, Shihua Dong,?Duanming Du and Lizhi Niu?(2018)?Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer. Cellular Physiology and Biochemistry, 47(4): 1556-1564.

3.?Shuzhen Liang,?Mao Lin, Lizhi Niu, Kecheng Xu, Xiaohua Wang, Yingqing Liang, Mingjie Zhan,Du Duanming and Chen Jibing (2018)?Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC). American?Journal of Cancer Research, 8(5): 879-891.

4.?Yumei Yang, Zilin Qin,?Duanming Du, Yumin, Shuibo Qiu, Feng Mu, Kengcheng Xu and Jibing Chen (2018).?Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver?Cancer. Cardiovascular and Interventional Radiology, 42(1): 48-59.

5.?Nong Yang, Yi Li, Zhidong Liu, Hao Qin, Duanming Du, Xinkai Cao,?Xiaoqing Cao, Jun Li, Dongge Li, Bo Jiang, Lincan Duan, Haiyan Yang, Zhenghua Zhang, Hao Lin, Jianying Li, Zhenhua Yang, Lei Xiong, Hua Shen, Lizhu Lin and Fugen Li (2018) The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues. BMC Cancer, 18(1): 319.

6.?Jibing Chen,?Zhongbao Pan,?Duanming Du, Wei Qian,?Yangyang Ma,?Feng Mu and Kecheng Xu?(2019)?Hydrogen gas therapy induced shrinkage of metastatic gallbladder cancer: A case report. World Journal of Clinical Cases,?7(15):?2065-2074.

7.?Jibing Chen,?Feng Mu,?Tianyu Lu,?Yangyang Ma,?Duanming Du and?Kecheng Xu (2019) A Gallbladder Carcinoma Patient With Pseudo-Progressive Remission After Hydrogen Inhalation, OncoTargets and Therapy, 12: 8645-8651.

8.?Jibing Chen, Xiaofeng Kong, Feng Mu, Tianyu Lu, Duanming Du and?Kecheng Xu (2019) Hydrogen–oxygen therapy can alleviate radiotherapy-induced hearing loss in patients with nasopharyngeal cancer. Annals of Palliative Medicine, 8(5): 746-751.

9.?Jibing Chen,?Feng Mu,?Tianyu Lu,?Duanming Du and Kecheng Xu (2019) Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report, OncoTargets and Therapy, 12: 11145-11151.

10.?Yumei Yang,?Yanfang Zhang,?Yumin Wu,?Jibing Chen,?Bing Liang,?Quanhong Chen,?Qiuyu Wang,?Jialing Lyu,?Yong Li,?Feng Mu and Duanming Du (2020) Efficacy and Safety of Percutaneous Argon-Helium Cryoablation for Hepatocellular Carcinoma Abutting the Diaphragm. Journal of Vascular and Interventional Radiology, 31(3): 393-400.

?

D. Research support

Ongoing projects (RMB)

Shenzhen Science and Technology R&D Fund (grant no. JCYJ20130329104732074), 2013-2015, Duanming Du, ￥300,000.

?